Randomised comparison of anticoagulation control and monitoring with versus without laboratory-provided computerized decision support
ISRCTN | ISRCTN27244875 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN27244875 |
Secondary identifying numbers | N/A |
- Submission date
- 08/11/2005
- Registration date
- 25/11/2005
- Last edited
- 14/09/2009
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Mr Michael Paterson
Scientific
Scientific
ICES
G106-2075 Bayview Ave.
Toronto, Ontario
M4N 3M5
Canada
Study information
Study design | Cluster-randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Not specified |
Study type | Not Specified |
Scientific title | |
Study objectives | Laboratory-provided computerized decision support will improve anticoagulation control relative to usual care |
Ethics approval(s) | Yes, August 2001 |
Health condition(s) or problem(s) studied | Various |
Intervention | Anticoagulation control and monitoring with versus without laboratory-provided computerized decision support (CDS) |
Intervention type | Other |
Primary outcome measure | 1. Acceptability of the CDS service, as assessed by the proportion of physicians who would continue to use it if offered 2. Estimated effectiveness, as assessed by percentage of time within target INR range |
Secondary outcome measures | Hemorrhagic and thromboembolic events requiring hospital attendance |
Overall study start date | 01/01/2002 |
Completion date | 30/06/2003 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Sex | Both |
Target number of participants | Physicians: 40; Patients: 380 |
Key inclusion criteria | Physicians: 1. Family or general practitioner 2. Full-time office practice 3. Practice address within study laboratory catchment area 4. At least 3 eligible patients willing to participate Patients: 1. On long-term warfarin therapy 2. Using the study laboratory for international normalized ratio (INR) tests and expecting to continue to do so for at least 12 months |
Key exclusion criteria | None |
Date of first enrolment | 01/01/2002 |
Date of final enrolment | 30/06/2003 |
Locations
Countries of recruitment
- Canada
Study participating centre
ICES
Toronto, Ontario
M4N 3M5
Canada
M4N 3M5
Canada
Sponsor information
Ontario Program for Optimal Therapeutics (Canada)
Not defined
Not defined
105 Main Street E, Level One
Hamilton, Ontario
L8N 1G6
Canada
https://ror.org/00tjpb250 |
Funders
Funder type
Not defined
Ontario Program for Optimal Therapeutics (Canada)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |